Sourcebio International Plc
Sourcebio International Plc (SBI.L) Stock Competitors & Peer Comparison
See (SBI.L) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
SBI.L | £115.00 | +4.55% | 0 | N/A | N/A | N/A |
0QNO.L | £573.20 | -0.66% | 39.1B | 14.50 | £39.52 | +0.69% |
0KHE.L | £87.79 | -5.44% | 10.7B | 14.68 | £6.16 | +0.31% |
IDHC.L | £0.36 | +0.85% | 206.4M | 8.88 | £0.04 | N/A |
0G8X.L | £0.46 | -1.24% | 186.1M | -0.06 | -£7.81 | N/A |
DXRX.L | £133.50 | +0.00% | 112.8M | -66.75 | -£0.02 | N/A |
AGL.L | £6.00 | +0.00% | 19.4M | -1.20 | -£0.05 | N/A |
YGEN.L | £0.51 | -0.47% | 16.4M | -0.51 | -£0.01 | N/A |
ABDX.L | £6.50 | +4.00% | 13.1M | -6.75 | -£0.01 | N/A |
PRM.L | £3.04 | +0.00% | 9M | -3.04 | -£0.01 | N/A |
Stock Comparison
SBI.L vs 0QNO.L Comparison August 2025
SBI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBI.L stands at 0. In comparison, 0QNO.L has a market cap of 39.1B. Regarding current trading prices, SBI.L is priced at £115.00, while 0QNO.L trades at £573.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBI.L currently has a P/E ratio of N/A, whereas 0QNO.L's P/E ratio is 14.50. In terms of profitability, SBI.L's ROE is +0.42%, compared to 0QNO.L's ROE of +0.07%. Regarding short-term risk, Volatility data is not available for a full comparison. SBI.L has daily volatility of N/A and 0QNO.L has daily volatility of 2.11.Check 0QNO.L's competition here